La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (Ncbi)

Index « Auteurs » - entrée « C. Brefel-Courbon »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
C. Brefel Courbon < C. Brefel-Courbon < C. Brenner  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000007 (1999) N. Abbas [France] ; C B Lücking ; S. Ricard ; A. Dürr ; V. Bonifati ; G. De Michele ; S. Bouley ; J R Vaughan ; T. Gasser ; R. Marconi ; E. Broussolle ; C. Brefel-Courbon ; B S Harhangi ; B A Oostra ; E. Fabrizio ; G A Böhme ; L. Pradier ; N W Wood ; A. Filla ; G. Meco ; P. Denefle ; Yves Agid [France] ; A. BriceA wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
000036 (1999) O. Rascol [France] ; C. Brefel-Courbon ; S. Descombes ; J L MontastrucClinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
000042 (1999) C. Thalamas [France] ; A. Taylor ; C. Brefel-Courbon ; S. Eagle ; K. Fitzpatrick ; O. RascolLack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.
000183 (2001) O. Rascol [France] ; N. Fabre ; C. Brefel-Courbon ; J L MontastrucThe pharmacologic treatment of gait ignition failure.
000189 (????) J L Montastruc [France] ; C. Brefel-Courbon ; J M Senard ; H. Bagheri ; J. Ferreira ; O. Rascol ; M. Lapeyre-MestreSleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study.
000191 (2001) J L Montastruc [France] ; K. Desboeuf ; M. Lapeyre-Mestre ; J M Senard ; O. Rascol ; C. Brefel-CourbonLong-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
000200 (2001) O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Yves Agid [France]Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
000201 (2001) J M Senard [France] ; C. Brefel-Courbon ; O. Rascol ; J L MontastrucOrthostatic hypotension in patients with Parkinson's disease: pathophysiology and management.
000274 (2002) O. Rascol [France] ; P. Payoux ; J. Ferreira ; C. Brefel-CourbonThe management of patients with early Parkinson's disease.
000289 (2003) Olivier Rascol [France] ; C. Brefel-Courbon ; P. Payoux ; J. FerreiraThe management of patients with early Parkinson's disease.
000414 (2003) P. Cintas [France] ; M. Simonetta-Moreau ; F. Ory ; C. Brefel-Courbon ; N. Fabre ; P. Chaynes ; J. Sabatier ; J C Sol ; O. Rascol ; I. Berry ; Y. LazorthesDeep brain stimulation for parkinson's disease: correlation between intraoperative subthalamic nucleus neurophysiology and most effective contacts.
000727 (2007) A. Gerdelat-Mas ; M. Simonetta-Moreau ; C. Thalamas ; F. Ory-Magne ; T. Slaoui ; O. Rascol ; C. Brefel-CourbonLevodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study
000A26 (2009) C. Brefel-Courbon [France][Digestive disturbances in Parkinson disease].
000C21 (2010) P. Payoux [France] ; C. Brefel-Courbon ; F. Ory-Magne ; W. Regragui ; C. Thalamas ; S. Balduyck ; F. Durif ; J P Azulay ; F. Tison ; O. Blin ; J P Esquerre ; O. RascolMotor activation in multiple system atrophy and Parkinson disease: a PET study.
000C31 (2011) V. Marchand-Pauvert [France] ; A. Gerdelat-Mas ; F. Ory-Magne ; F. Calvas ; D. Mazevet ; S. Meunier ; C. Brefel-Courbon ; M. Vidailhet ; M. Simonetta-MoreauBoth L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease.
000E95 (2012) S. Lesage [France] ; C. Condroyer ; S. Klebe ; A. Honoré ; F. Tison ; C. Brefel-Courbon ; A. Dürr ; A. BriceIdentification of VPS35 mutations replicated in French families with Parkinson disease.
001F29 (1998) J L Montastruc [France] ; M. Pelat ; P. Verwaerde ; C. Brefel-Courbon ; M A Tran ; O. Blin ; O. Rascol ; J M SenardFluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot study.
001F42 (????) O. Rascol [France] ; C. Brefel-Courbon ; O. Blin[Clinical pharmacology of dyskinesias induced by L-dopa in Parkinsonian patients].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "C. Brefel-Courbon" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "C. Brefel-Courbon" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    C. Brefel-Courbon
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024